Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
What is missing There is no published human pharmacokinetic study of subcutaneous AOD-9604, no published human topical or intranasal exposure data, no Phase 3 efficacy trial, no long-term safety data beyond 24 weeks, and no published human cartilage or joint outcome data
Thymosin Alpha-1 FDA Status: Approved in other countries
[32] Desai HG, Gupte PA
One theory is that mental health problems are caused by high homocysteine levels (vitamin B12 is needed to break down this chemical)
Synergy: The combination covers both the localized repair signal and the systemic mobilization response, producing faster and higher-quality healing than either peptide alone
